Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Zydus Lifesciences Ltd (ZYDU)

NSE
Currency in INR
Disclaimer
1,006.10
+6.40(+0.64%)
Closed

ZYDU Comments

https://www.business-standard.com/article/news-cm/zydus-cadila-receives-usfda-final-approval-for-emtricitabine-and-tenofovir-disoproxil-fumarate-tablets-121070200631_1.html
Buy bandhan bank shrot term target 400++
Now expiry is tommorow be careful ,It may go to 615 from where it wl bounce back for upward journey sure
Most of the retailer out now due to panic at downside prize & cadila may be at 680 by Monday and 755 by expiry
today may regain till 655
going down to 630
CADILA HELTH CARE has thee good news .1. Emergency approval of corona vaccine any time .2. one husbandry business sell deal news any time ( deal almost done)3.one medicine tentetive approved by FDA.4. GST on black fungus drug produced by cadila slashed to o .expecting good move in cadila in short term it will reach 950 .swith some money to cadila for quick reyurn
cadila hitted soon 645++
is it right time to sell cadilahc??
670
next target 625 posibale
next target 625 posibale
yes Monday 600
500
I think now cadila move 600 above Monday big blast happen
how to buy thesei am not able to buy
what is tgt today cadila
550
Buy, and exit at 650
bought 510 CE of feb few days ago 10 lots. sitting on huge loss. knowledgeable boarders please advise
never give yourself too little room for any adverse price actions , buying short expiry has huge risk (also huge rewards too) bit you need to balance your risk and reward to be in game for long time
hope by this time you have already liquidated your position
why it's dropping despite bullish sentiments?
why it's dropping despite bullish sentiments?
Buy Chembond at 168-170 target 200++
is it right time to sell this share ?
no time to buy
is this right time to buy this share any target price for this share
I have this stock for intraday today levels available @ private chat portal. You can look one side move.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.